Intelligence · Clinical Pipeline
Sunshine Guojian Pharmaceutical Pipeline
All ClinicalTrials.gov programs at Sunshine Guojian Pharmaceutical — phase, modality, and trial IDs.
- Programs
- 5
Quick answer
Sunshine Guojian Pharmaceutical has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Ceftolozane/tazobactam
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Bronchiectasis
1 trial -
EPIAO®
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Renal Anaemia
1 trial -
Sulforaphane
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
HIV Infections
1 trial -
TPO
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
ITP
1 trial -
rhTPO
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Previously Treated Primary Immune Thrombocytopenia
1 trial
Frequently asked questions
How many pipeline programs does Sunshine Guojian Pharmaceutical have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs